From: Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival
OPTIMAL
WARNING
FAILURE
No.of patients,n (%)
109 (72.66)
18 (12)
23 (15.33)
